Navigation Links
Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
Date:2/24/2013

any Xolair injection. Anaphylaxis has occurred after the first Xolair injection or after many Xolair injections.

A patient's healthcare provider should watch the patient for some time in the office for signs or symptoms of anaphylaxis after injecting Xolair. If patients have signs or symptoms of anaphylaxis, they must tell their healthcare provider right away.

Patients must not receive Xolair if they have ever had an allergic reaction to a Xolair injection. Patients should not use Xolair if they are allergic to any of its ingredients.

In clinical studies, a variety of cancer types, including breast, skin, prostate, and parotid (a type of salivary gland), were reported in more patients who received Xolair than in patients who did not receive Xolair.

Xolair is not a rescue medicine and should not be used to treat sudden asthma attacks.

Xolair is not a substitute for the medicines patients are already taking. Patients must not change or stop taking any of their other asthma medicines unless their doctor tells them to do so.

Some patients on Xolair may have an abnormal increase in eosinophils (a type of white blood cell) in the blood or tissues, sometimes causing an inflammation of blood vessels which can lead to rash, worsening of respiratory symptoms, heart trouble, and/or nerve pain and weakness.

Joint inflammation or pain, rash, fever, and swollen lymph nodes have been seen in some patients taking Xolair after the first or subsequent injections. Patients should talk to their doctor if they have experienced any of these signs and symptoms.

In allergic asthma studies, the most commonly seen side effects occurring more frequently in patients receiving Xolair than in patients who received placebo (an injection with no active medicine) were joint pain, pain (general), leg pain, tiredness (fatigue), dizziness, fracture, arm pain, itching, inflammation of the skin, and earache.

In allergic asthma studies
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Novartis Pharma Logistics, Inc. voluntarily recalling in Jamaica select lots of certain over-the-counter products due to bottle closure defect
2. Novartis Pharma Logistics, Inc. voluntarily recalling in Trinidad & Tobago select lots of certain over-the-counter products due to bottle closure defect
3. Novartis Pharma Logistics, Inc. voluntarily recalling in Curacao select lots of certain over-the-counter products due to bottle closure defect
4. Novartis Pharma Logistics, Inc. voluntarily recalling in Aruba select lots of certain over-the-counter products due to bottle closure defect
5. Novartis Pharma Logistics, Inc. voluntarily recalling in Barbados select lots of certain over-the-counter products due to bottle closure defect
6. Continued Uptake of Novartis/Incytes Jakafi Will Be the Greatest Driver of Growth in the Myelofibrosis Therapy Market
7. Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
8. Thesan Pharmaceuticals offentliggør første runde af venturefinansieringen ledt af Novo Ventures og Novartis Venture Funds i fællesskab
9. Thesan Pharmaceuticals annuncia un finanziamento di serie A co-gestito da Novo Ventures e Novartis Venture Funds
10. Thesan Pharmaceuticals gibt Serie-A-Finanzierung unter gemeinsamer Führung von Novo Ventures und Novartis Venture Funds bekannt
11. Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Boehringer Ingelheim will contribute to advancing the ... Thoracic Society International Conference (ATS 2013) in ... 22. Data will highlight research conducted ... chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler® (tiotropium ... for asthma, idiopathic pulmonary fibrosis (IPF) and COPD. ...
(Date:5/17/2013)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( ... announced today that the United States Food and Drug ... application(IND) for ORMD-0801, its oral insulin capsule. ... to proceed," stated Nadav Kidron , ... milestone for Oramed and we look forward to continuing ...
(Date:5/16/2013)... and MECHELEN, Belgium , ... and AbbVie (NYSE: ABBV ) announced today ... include Crohn,s disease.  Galapagos will fund and complete a ... to facilitate rapid progression into Phase 3.  Upon successful ... will pay Galapagos $50 million.  The terms of the ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... , the leading employment website for medical device and ... Campaign this morning, marking the campaign,s fourth edition, ... http://photos.prnewswire.com/prnh/20040907/CLTU006LOGO) Each participant company,s brand is added ... that is promoted online as well as at industry ...
... 27, 2011 /PRNewswire-iReach/ -- URINOZINC® Plus with ... line, is now available for purchase at select Walmart ... URINOZINC® is the only dietary supplement with a US ... prostate.  Over 2 million bottles have been sold. ...
Cached Medicine Technology:DeviceSpace Campaign Features Medical Device and Diagnostics Companies 2Walmart Stores Now Offer URINOZINC® Plus With Beta-Sitosterol 2
(Date:5/19/2013)... (PRWEB) May 19, 2013 The Da ... to follow developments in the nation’s first trial involving ... underway in Washington State Superior Court, was filed by ... after he suffered complications in a robot-assisted prostate removal, ... Da Vinci robotic surgery lawsuit alleges those ...
(Date:5/18/2013)... Each year, the American Gastroenterological Association (AGA) ... achievements in gastroenterology through its esteemed recognition awards. ... talented individuals who work tirelessly to advance the ... pleased to announce the 2013 recognition award honorees ... their tremendous contributions to our field," said Loren ...
(Date:5/18/2013)... FRIDAY, May 17 (HealthDay News) -- As the American ... considered the "bible" of modern psychiatry this weekend, the ... unprecedented, the amount of commentary and debate and criticism," ... Association (APA). "It,s been an interesting phenomenon, but the ... it and then make your own determination of how ...
(Date:5/18/2013)... FL (May 18, 2013) There are significant ... commonly used to diagnose or treat gastrointestinal problems, ... (DDW). , A study by New York ... more objective testing may substantially reduce the cost ... Although GERD is believed to affect nearly 25 ...
(Date:5/18/2013)... Park City, Utah (PRWEB) May 18, 2013 ... new information on insurance agents’ role in ... flexible alternatives to traditional employer sponsored health benefits, ... defined contribution and health reimbursement arrangements ... Department of Health and Human Services (HHS) recently ...
Breaking Medicine News(10 mins):Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 3Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 5Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 2Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 3Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 4Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4
... Researchers at the Yerkes National Primate Research Center, Emory ... growth and generation of several types of neural cells. ... of the journal Stem Cells , suggest dental ... therapy and regenerative medicine, particularly therapies associated with the ...
... major cardiovascular event by more ... may anticipate a role for genetic testing in association with ... clopidogrel prescribing, FRANKLIN LAKES, N.J., ... study at the 2008 Scientific,Sessions of the American Heart Association that showed an ...
... Texas Instruments,(NYSE: TXN ) (TI) ... 15 dedicated,embedded processors which enable faster, more ... imaging equipment manufacturers to develop,new modalities or ... portable.,These processors target several medical imaging applications ...
... 11 Orthodontists have been,straightening teeth for decades ... a reaction," in which tooth displacement in one ... as well. Use of dental implants as,orthodontic anchors, ... and expanding possibilities for previously untreatable,cases, according to ...
... Nov. 11 Two men from Worcester,Massachusetts have completed ... and funding to help families affected by autism. Robert,Williams ... 13th in San,Francisco, CA. Their six-month journey ended at ... for the National Autism Association (NAA) in memory of,Elias ...
... positive U.S. health trend documented over the past 30 years ... strong as is widely perceived - and, in fact, the ... data by Mayo Clinic. , This suggests that the ... than is commonly thought, says Francisco Lopez-Jimenez, M.D., cardiologist and ...
Cached Medicine News:Health News:New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug 2Health News:New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug 3Health News:New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug 4Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 2Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 3Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 4Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 5Health News:Dental Implants Effective for Orthodontic Treatment 2Health News:Two Men Complete First-Ever Walk Across the Country for Autism 2Health News:Past gains in reducing risk of heart disease have flattened, women especially affected 2
... Multi-Use Reposable Clip Applier ... disposables with the economics ... superior instrument balance and ... cartridges. The multi-use Reposable ...
Finally, security and dependability in an automatic 5mm clip applier!...
Pilling-Weck, medium-large clip size, 10mm, rotatable take apart...
Insert only, Pilling-Weck small clip size...
Medicine Products: